# Jing Hu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jing-hu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 79 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 4 |
| i10-index | 1 |
| Last Known Institution | First Affiliated Hospital of Jiangxi Medical College |
| OpenAlex ID | https://openalex.org/A5040316729 |
| ORCID iD | 0009-0008-1278-2800 |
| Works | 11 |

## Researcher papers

- [High-density Lipoprotein and Inflammation and Its Significance to Atherosclerosis](https://scholariq.org/papers/high-density-lipoprotein-and-inflammation-and-its-significance-to/)
- [Prognostic value of low-density lipoprotein cholesterol in IgA nephropathy and establishment of nomogram model](https://scholariq.org/papers/prognostic-value-of-low-density-lipoprotein-cholesterol-in-iga-nephropathy-and/)
- [AB045. P-13. Genomic heterogeneity between Asian and Western intrahepatic cholangiocarcinoma](https://scholariq.org/papers/ab045-p-13-genomic-heterogeneity-between-asian-and-western-intrahepatic/)
- [The clinicopathological features and renal prognostic factors in pure membranous lupus nephritis—a large series cohort study from China](https://scholariq.org/papers/the-clinicopathological-features-and-renal-prognostic-factors-in-pure-membranous/)
- [Baolier Capsule’s Secret Weapon: Piperine Boosts Cholesterol Excretion to Combat Atherosclerosis](https://scholariq.org/papers/baolier-capsule-s-secret-weapon-piperine-boosts-cholesterol-excretion-to-combat/)
- [\[Clinical value of apolipoprotein B versus low-density lipoprotein cholesterol in assessing risks of coronary artery disease\].](https://scholariq.org/papers/clinical-value-of-apolipoprotein-b-versus-low-density-lipoprotein-cholesterol-in/)
- [Comparison of curative effects of amisulpride and risperidone in the treatment of patients with first-episode schizophrenia](https://scholariq.org/papers/comparison-of-curative-effects-of-amisulpride-and-risperidone-in-the-treatment/)
- [Discovery of Dysimmunity in Large Granular Lymphocytic Leukemia (LGLL) using Bioinformatic Analysis](https://scholariq.org/papers/discovery-of-dysimmunity-in-large-granular-lymphocytic-leukemia-lgll-using/)
- [Cetuximab Combined with Vemurafenib Can Significantly Inhibit the Proli- Feration Of Braf V600e Mutant Egfr Wild-Type Colorectal Cancer Cells](https://scholariq.org/papers/cetuximab-combined-with-vemurafenib-can-significantly-inhibit-the-proli-feration/)
- [Risk Factors of Brain Metastasis in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer](https://scholariq.org/papers/risk-factors-of-brain-metastasis-in-patients-with-egfr-mutated-advanced-non/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Cancer Research and Treatments](https://scholariq.org/topics/cancer-research-and-treatments/)
- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)
- [Autism Spectrum Disorder Research](https://scholariq.org/topics/autism-spectrum-disorder-research/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)

## Researcher university

- [First Affiliated Hospital of Jiangxi Medical College](https://scholariq.org/institutions/first-affiliated-hospital-of-jiangxi-medical-college/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.